Loading
No description yet: the sentence for this tag has not been written. 2 records carry it: 2 protocols.
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Heart risk assessment and monitoring before, during and after heart-toxic cancer treatment Some cancer treatments, such as anthracyclines (doxorubicin, epirubicin) and trastuzumab, can weaken the heart. Before they start, your team should check your heart risk, usually with blood pressure, blood tests, an ECG and a heart scan, repeated during treatment; a fall in heart function does not always mean stopping. Afterwards, tell any doctor about new breathlessness, swelling or chest pain. | none | none | protocol, survivorship | ||
Immune-related myocarditis from checkpoint inhibitors Rarely, immunotherapy inflames the heart muscle. It usually starts in the first three months and can be fatal, so new chest pain, breathlessness, palpitations, fainting, or new muscle weakness, drooping eyelids or double vision need urgent assessment. It is treated in hospital with very high-dose steroids straight away. | none | none | protocol, irae, acute-oncology |